Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-20

Clinical Trial Update: Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer [NA]

View source ↗

Summary

The clinical trial evaluating optical coherence tomography for staging upper tract urothelial carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Kidney/Urinary Cancer | NA | Status: WITHDRAWN